Bridging Evidence-Based Practice and Practice-Based Evidence in Periprocedural Anticoagulation

被引：51

作者：

Gallego, Pilar ^{[1
]}

Apostolakis, Stavros ^{[1
]}

Lip, Gregory Y. H. ^{[1
]}

机构：

[1] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England

来源：

CIRCULATION | 2012年 / 126卷 / 13期

关键词：

Editorials; warfarin; RHYTHM ASSOCIATION EHRA; ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; CONSENSUS DOCUMENT; WARFARIN INTERRUPTION; ORAL ANTICOAGULANTS; EUROPEAN-SOCIETY; WORKING GROUP; MANAGEMENT; THROMBOSIS;

D O I：

10.1161/CIRCULATIONAHA.112.135681

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1573 / 1576

页数：4

共 20 条

[1]

Canadian Institutes of Health Research, NCT00800137 CAN I HL

[2] Contra: "Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery" [J].

Douketis, James D. .

THROMBOSIS AND HAEMOSTASIS, 2012, 108 (02) :210-212

[3] Perioperative management of patients receiving oral anticoagulants - A systematic review [J].

Dunn, AS ;

Turpie, AGG .

ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (08) :901-908

[4] Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting A North-American perspective [J].

Faxon, David P. ;

Eikelboom, John W. ;

Berger, Peter B. ;

Holmes, David R. ;

Bhatt, Deepak L. ;

Moliterno, David J. ;

Becker, Richard C. ;

Angiolillo, Dominick J. .

THROMBOSIS AND HAEMOSTASIS, 2011, 106 (04) :572-584

[5] Executive Summary Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].

Guyatt, Gordon H. ;

Akl, Elie A. ;

Crowther, Mark ;

Gutterman, David D. ;

Schuenemann, Holger J. .

CHEST, 2012, 141 (02) :7S-47S

[6] Bleeding risk assessment and management in atrial fibrillation patients Executive Summary* of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis [J].

Lip, Gregory Y. H. ;

Andreotti, Felicita ;

Fauchier, Laurent ;

Huber, Kurt ;

Hylek, Elaine ;

Knight, Eve ;

Lane, Deirdre ;

Levi, Marcel ;

Marin, Francisco ;

Palareti, Gualtiero ;

Kirchhof, Paulus .

THROMBOSIS AND HAEMOSTASIS, 2011, 106 (06) :997-1011

[7] Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation [J].

Lip, Gregory Y. H. ;

Nieuwlaat, Robby ;

Pisters, Ron ;

Lane, Deirdre A. ;

Crijns, Harry J. G. M. .

CHEST, 2010, 137 (02) :263-272

[8] Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI] [J].

Lip, Gregory Y. H. ;

Huber, Kurt ;

Andreotti, Felicita ;

Arnesen, Harald ;

Airaksinen, K. Juhani ;

Cuisset, Thomas ;

Kirchhof, Paulus ;

Marin, Francisco .

THROMBOSIS AND HAEMOSTASIS, 2010, 103 (01) :13-28

[9] Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence [J].

Miyasaka, Yoko ;

Barnes, Marion E. ;

Gersh, Bernard J. ;

Cha, Stephen S. ;

Bailey, Kent R. ;

Abhayaratna, Walter P. ;

Seward, James B. ;

Tsang, Teresa S. M. .

CIRCULATION, 2006, 114 (02) :119-125

[10]

National Institutes of Health Clinical Center, NCT00432796 NAT I HL

← 1 2 →